Old Web
English
Sign In
Acemap
>
authorDetail
>
R Gedrich
R Gedrich
Medicine
Sorafenib
Myeloid leukemia
Cell growth
Leukemia
4
Papers
143
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
210 A phase 1 study of KTN3379, a human anti-ErbB3 monoclonal antibody in patients with advanced cancers
2014
European Journal of Cancer
Patricia LoRusso
Theresa M. LaVallee
L. Kimmel
C. Lubeski
R Gedrich
Carolyn F. Sidor
Show All
Source
Cite
Save
Citations (1)
Antitumor activity of sorafenib in FLT3-driven leukemic cells
2007
Leukemia
Daniel Auclair
D. Miller
V Yatsula
Walter Pickett
Christopher Carter
Yong S. Chang
Xiaomei Zhang
Dean Wilkie
A Burd
H. Shi
S Rocks
R Gedrich
L Abriola
H Vasavada
Mark Lynch
Jacques Dumas
Pamela A. Trail
Scott Wilhelm
Show All
Source
Cite
Save
Citations (141)
ORIGINAL ARTICLE Antitumor activity of sorafenib in FLT3-driven leukemic cells
2007
Daniel Auclair
D. Miller
V Yatsula
Walter Pickett
Christopher Carter
Yong S. Chang
Xiaomei Zhang
Dean Wilkie
A Burd
H. Shi
S Rocks
R Gedrich
L Abriola
H Vasavada
Mark Lynch
Jacques Dumas
Pamela A. Trail
Scott Wilhelm
Show All
Source
Cite
Save
Citations (0)
572 POSTER Sorafenib (BAY 43-9006) inhibits imatinib-resistant mutant KIT signaling
2006
Ejc Supplements
R Gedrich
E. Sullivan
H. Shi
M. Brown
S Rocks
A Burd
L. Liu
S. Wihelm
Show All
Source
Cite
Save
Citations (1)
1